Title: Shankar Kumar: Innovator in Antibody Development
Introduction
Shankar Kumar is a notable inventor based in the United States, recognized for his contributions to the field of biotechnology. His work primarily focuses on the development of antibodies with potential therapeutic applications. Despite having no patents to his name, his research has significant implications for cancer treatment.
Latest Patents
Shankar Kumar's latest invention is titled "Anti-Human Trop-2 Antibody Having An Antitumor Activity In Vivo." This invention provides an antibody that specifically reacts with hTROP-2 and exhibits anti-tumor activity in vivo, particularly as a humanized antibody. The invention includes a hybridoma that produces the antibody, a conjugate of the antibody and a drug, a pharmaceutical composition for diagnosing or treating tumors, a method for detecting tumors, and a kit for tumor detection and diagnosis. The antibody's heavy chain and light chain CDRs are detailed in SEQ ID NOS: 33 to 38 and 41 to 43 (HuK5-70 and HuK5-70-2).
Career Highlights
Throughout his career, Shankar Kumar has worked with various companies, including Gene Techno Science Co., Ltd. and Livtech, Inc. His experience in these organizations has contributed to his expertise in antibody development and cancer research.
Collaborations
Shankar has collaborated with notable colleagues such as J Yun Tso and Naoya Tsurushita, enhancing his research through shared knowledge and expertise.
Conclusion
Shankar Kumar's innovative work in antibody development showcases his commitment to advancing cancer treatment. His contributions, particularly in the area of anti-human Trop-2 antibodies, highlight the potential for significant breakthroughs in oncology.